Skip to main content
. 2018 Jun 12;9:617. doi: 10.3389/fphar.2018.00617

Table 3.

Effects of the quercetin, myricetin and CAPE on COX-1 and COX-2 activity.

Compound COX-1 COX-2

Inhibition (%) Inhibition (%)
Diclofenac (10 μM) 79.08 ± 6.93 86.54 ± 4.13
Quercetin (10 μM) 62.75 ± 14.73 15.43 ± 1.26
Myricetin (10 μM) 1.00 ± 0.65 10.35 ± 2.20
C. adamantium peel extract (10 mg/mL) 96.13 ± 0.75 89.88 ± 1.99

Values are presented as mean ± SEM (n = 4).